14 [83] I. Irrcher, V. Ljubicic, A. F. Kirwan, and D. A. Hood, “AMP- activated protein kinase-regulated activation of the PGC- 1alpha promoter in skeletal muscle cells,” PLoS ONE, vol. 3, no. 10, Article ID e3614, 2008. [84] T. Akimoto, S. C. Pohnert, P. Li et al., “Exercise stimulates Pgc-1α transcription in skeletal muscle through activation of the p38 MAPK pathway,” Journal of Biological Chemistry, vol. 280, no. 20, pp. 19587–19593, 2005. [85] C. Kang, K. M. O’Moore, J. R. Dickman, and L. L. Ji, “Exer- cise activation of muscle peroxisome proliferator-activated receptor-γ coactivator-1α signaling is redox sensitive,” Free Radical Biology and Medicine, vol. 47, no. 10, pp. 1394–1400, 2009. [86] B. M. Spiegelman, “Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators,” Novartis Foundation Symposium, vol. 287, pp. 60–63, 2007. [87] R. Scherz-Shouval, E. Shvets, E. Fass, H. Shorer, L. Gil, and Z. Elazar, “Reactive oxygen species are essential for autophagy and speciﬁcally regulate the activity of Atg4,” EMBO Journal, vol. 26, no. 7, pp. 1749–1760, 2007. [88] G. Kroemer and B. Levine, “Autophagic cell death: the story of a misnomer,” Nature Reviews Molecular Cell Biology, vol. 9, no. 12, pp. 1004–1010, 2008. [89] R. Singh and A. M. Cuervo, “Autophagy in the cellular energetic balance,” Cell Metabolism, vol. 13, no. 5, pp. 495– 504, 2011. [90] T. Kirisako, Y. Ichimura, H. Okada et al., “The reversible modiﬁcation regulates the membrane-binding state of Apg8/Aut7 essential for autophagy and the cytoplasm to vacuole targeting pathway,” Journal of Cell Biology, vol. 151, no. 2, pp. 263–275, 2000. [91] R. Scherz-Shouval, E. Shvets, and Z. Elazar, “Oxidation as a post-translational modiﬁcation that regulates autophagy,” Autophagy, vol. 3, no. 4, pp. 371–373, 2007. [92] Y. Chen, E. McMillan-Ward, J. Kong, S. J. Israels, and S. B. Gibson, “Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells,” Cell Death and Diﬀerentiation, vol. 15, no. 1, pp. 171–182, 2008. [93] G. Dobrowolny, M. Aucello, E. Rizzuto et al., “Skeletal muscle is a primary target of SOD1G93A-mediated toxicity,” Cell Metabolism, vol. 8, no. 5, pp. 425–436, 2008. [94] M. Aucello, G. Dobrowolny, and A. Musaro` , “Localized accumulation of oxidative stress causes muscle atrophy through activation of an autophagic pathway,” Autophagy, vol. 5, no. 4, pp. 527–529, 2009. [95] C. Mammucari, G. Milan, V. Romanello et al., “FoxO3 con- trols autophagy in skeletal muscle in vivo,” Cell Metabolism, vol. 6, no. 6, pp. 458–471, 2007. [96] M. Sandri, “Autophagy in health and disease. 3. Involve- ment of autophagy in muscle atrophy,” American Journal of Physiology—Cell Physiology, vol. 298, no. 6, pp. C1291– C1297, 2010. [97] J. Zhao, J. J. Brault, A. Schild et al., “FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells,” Cell Metabolism, vol. 6, no. 6, pp. 472–483, 2007. [98] M. Bar-Shai, E. Carmeli, and A. Z. Reznick, “The role of NF-κB in protein breakdown in immobilization, aging, and exercise: from basic processes to promotion of health,” Annals of the New York Academy of Sciences, vol. 1057, pp. 431–447, 2005. [99] C. Deval, S. Mordier, C. Obled et al., “Identiﬁcation of cathepsin L as a diﬀerentially expressed message associated Journal of Signal Transduction with skeletal muscle wasting,” Biochemical Journal, vol. 360, part 1, pp. 143–150, 2001. [100] J. J. Lemasters, “Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging,” Rejuvenation Re- search, vol. 8, no. 1, pp. 3–5, 2005. [101] E. Masiero, L. Agatea, C. Mammucari et al., “Autophagy is required to maintain muscle mass,” Cell Metabolism, vol. 10, no. 6, pp. 507–515, 2009. [102] I. Tanida, T. Ueno, and E. Kominami, “LC3 conjugation system in mammalian autophagy,” International Journal of Biochemistry and Cell Biology, vol. 36, no. 12, pp. 2503–2518, 2004. [103] A. J. Primeau, P. J. Adhihetty, and D. A. Hood, “Apoptosis in heart and skeletal muscle,” Canadian Journal of Applied Physiology, vol. 27, no. 4, pp. 349–395, 2002. [104] M. L. Circu and T. Y. Aw, “Reactive oxygen species, cellular redox systems, and apoptosis,” Free Radical Biology and Medicine, vol. 48, no. 6, pp. 749–762, 2010. [105] E. E. Dupont-Versteegden, B. A. Strotman, C. M. Gurley et al., “Nuclear translocation of EndoG at the initiation of dis- use muscle atrophy and apoptosis is speciﬁc to myonuclei,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 291, no. 6, pp. R1730–R1740, 2006. [106] M. Madesh and G. Hajno´ czky, “VDAC-dependent permeabi- lization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release,” Journal of Cell Biology, vol. 155, no. 6, pp. 1003–1015, 2001. [107] F. Tomasello, A. Messina, L. Lartigue et al., “Outer mem- brane VDAC1 controls permeability transition of the inner mitochondrial membrane in cellulo during stress-induced apoptosis,” Cell Research, vol. 19, no. 12, pp. 1363–1376, 2009. [108] D. A. Hildeman, T. Mitchell, B. Aronowt, S. Wojciechowski, J. Kappler, and P. Marrack, “Control of Bcl-2 expression by reactive oxygen species,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 25, pp. 15035–15040, 2003. [109] N. Azad, A. Iyer, V. Vallyathan et al., “Role of oxida- tive/nitrosative stress-mediated Bcl-2 regulation in apoptosis and malignant transformation,” Annals of the New York Academy of Sciences, vol. 1203, pp. 1–6, 2010. [110] M. Giorgio, E. Migliaccio, F. Orsini et al., “Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis,” Cell, vol. 122, no. 2, pp. 221–233, 2005. [111] P. Pinton, A. Rimessi, S. Marchi et al., “Protein kinase C β and prolyl isomerase 1 regulate mitochondrial eﬀects of the life-span determinant p66Shc,” Science, vol. 315, no. 5812, pp. 659–663, 2007. [112] N. S. Dhalla, A. B. Elmoselhi, T. Hata, and N. Makino, “Status of myocardial antioxidants in ischemia-reperfusion injury,” Cardiovascular Research, vol. 47, no. 3, pp. 446–456, 2000. [113] M. A. Pellegrino, J.-F. Desaphy, L. Brocca, S. Pierno, D. C. Camerino, and R. Bottinelli, “Redox homeostasis, oxidative stress and disuse muscle atrophy,” Journal of Physiology, vol. 589, no. 9, pp. 2147–2160, 2011. [114] P. J. Adhihetty, T. Taivassalo, R. G. Haller, D. R. Walkinshaw, and D. A. Hood, “The eﬀect of training on the expression of mitochondrial biogenesis- and apoptosis-related proteins in skeletal muscle of patients with mtDNA defects,” American Journal of Physiology—Endocrinology and Metabolism, vol. 293, no. 3, pp. E672–E680, 2007.